These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35076441)

  • 41. Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
    Peckham AM; Ball J; Colvard MD; Dadiomov D; Hill LG; Nichols SD; Tallian K; Ventricelli DJ; Tran TH
    Am J Health Syst Pharm; 2021 Mar; 78(7):613-618. PubMed ID: 33411894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic.
    Mutter R; Black J; Iwanicki J
    Psychiatr Serv; 2023 Jan; 74(1):63-65. PubMed ID: 35770425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in Opioid Medication Adherence During the COVID-19 Pandemic: Retrospective Cohort Study.
    Marashi A; Warren D; Call G; Dras M
    JMIR Public Health Surveill; 2023 Sep; 9():e42495. PubMed ID: 37656492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020.
    Jones CM; Guy GP; Board A
    Drug Alcohol Depend; 2021 Feb; 219():108486. PubMed ID: 33421802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Public transport access to drug treatment before and during COVID-19: Implications for the opioid epidemic.
    Yücel SG; Higgins CD; Gupta K; Palm M
    Int J Drug Policy; 2023 Jun; 116():104032. PubMed ID: 37172439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concerns among people who use opioids during the COVID-19 pandemic: a natural language processing analysis of social media posts.
    Sarker A; Nataraj N; Siu W; Li S; Jones CM; Sumner SA
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):16. PubMed ID: 35248103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
    Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
    J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of COVID-19 on opioid treatment program (OTP) services: Where do we go from here?
    Tracy K; Wachtel L; Friedman T
    J Subst Abuse Treat; 2021 Dec; 131():108394. PubMed ID: 34098292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evolution of the national opioid crisis.
    Morland R
    Nursing; 2019 May; 49(5):51-56. PubMed ID: 31022031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period.
    Jones HE; Hairston E; Lensch AC; Marcus LK; Heil SH
    Prev Med; 2021 Nov; 152(Pt 2):106742. PubMed ID: 34302836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection.
    Eagleton M; Stokes S; Fenton F; Keenan E
    Br J Anaesth; 2021 Dec; 127(6):e212-e214. PubMed ID: 34556330
    [No Abstract]   [Full Text] [Related]  

  • 52. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.
    Green TC; Bratberg J; Finnell DS
    Subst Abus; 2020; 41(2):147-149. PubMed ID: 32314951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report.
    Flavin L; Tofighi B; Krawczyk N; Schatz D; McNeely J; Butner J
    J Addict Med; 2022 Jan-Feb 01; 16(1):e59-e61. PubMed ID: 35120069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic.
    Tilhou AS; Dague L; Saloner B; Beemon D; Burns M
    JAMA Health Forum; 2022 Mar; 3(3):e220093. PubMed ID: 35977284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Community Partnership to Improve Access to Buprenorphine in a Homeless Population.
    Leo P; Gastala N; Fleurimont J; Messmer S; Maes P; Richardson J; Neeb C; Stackhouse N; Koruba S; Watson DP
    Ann Fam Med; 2021; 19(1):85. PubMed ID: 33431401
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Confronting Two Crises: The COVID-19 Pandemic, the Opioid Epidemic, and the Industrial Hygienist.
    Rosen J; Harnett P
    New Solut; 2021 Nov; 31(3):384-389. PubMed ID: 34233539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
    Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR
    Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469
    [No Abstract]   [Full Text] [Related]  

  • 60. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.